Compare · ACN vs AHG
ACN vs AHG
Side-by-side comparison of Accenture plc (ACN) and Akso Health Group (AHG): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ACN and AHG operate in Real Estate (Real Estate), so they compete in similar markets.
- ACN is the larger of the two at $93.51B, about 117.7x AHG ($794.7M).
- Over the past year, ACN is down 51.2% and AHG is down 24.8% - AHG leads by 26.4 points.
- ACN has hit the wire 15 times in the past 4 weeks while AHG has been quiet.
- ACN has more recent analyst coverage (25 ratings vs 0 for AHG).
- Company
- Accenture plc
- Akso Health Group
- Price
- $142.00+0.74%
- $1.50-6.25%
- Market cap
- $93.51B
- $794.7M
- 1M return
- +12.21%
- +19.05%
- 1Y return
- -51.18%
- -24.81%
- Industry
- Real Estate
- Real Estate
- Exchange
- NYSE
- NASDAQ
- IPO
- 2001
- 2017
- News (4w)
- 15
- 0
- Recent ratings
- 25
- 0
Accenture plc
Accenture plc, a professional services company, provides strategy and consulting, interactive, and technology and operations services worldwide. The company also provides outsourcing services. It serves communications, media, high tech, software, and platform companies; banking, capital market, and insurance industries; and consumer goods, retail, travel services, industrial, and life science industries, as well as clients in health, public service, chemicals and natural resources, energy, and utility sectors. Accenture plc has alliance relationships with Adobe, Alibaba, Amazon Web Services, Blue Yonder, Cisco, Dell, Google, HPE, IBM RedHat, Microsoft, Oracle, Pegasystems, Salesforce, SAP, ServiceNow, VMWare, Workday, Massachusetts Institute of Technology, Institut Polytechnique de Paris, CNH Industrial, and Reactive Technologies. It has an agreement with Duke Energy Corporation for the development of a technology platform designed to measure actual baseline methane emissions from natural gas distribution systems. The company was incorporated in 2009 and is based in Dublin, Ireland.
Akso Health Group
Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, etc. It also offers consultancy and information technology support services; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Beijing, China. As of July 13, 2021, Akso Health Group operates as a subsidiary of Webao Limited.
Latest ACN
- SEC Form 8-K filed by Accenture plc
- SEC Form FWP filed by Accenture plc
- NATO Announces Major Contract with Accenture to Help Advance Towards a More Agile and Resilient Digital Infrastructure
- Accenture Edge and Google Cloud Bring Scalable Agentic AI Solutions to Mid-Market Companies
- General Counsel/Corp Secretary Unruch Joel was granted 202 units of Class A ordinary shares, increasing direct ownership by 0.72% to 28,233 units (SEC Form 4)
- Chair and CEO Sweet Julie Spellman was granted 285 units of Class A ordinary shares, increasing direct ownership by 2% to 16,520 units (SEC Form 4)
- Chief Operating Officer Hogan Catherine Kiernan was granted 157 units of Class A ordinary shares, increasing direct ownership by 1% to 13,478 units (SEC Form 4)
- Chief Accounting Officer Burgum Melissa A was granted 147 units of Class A ordinary shares, increasing direct ownership by 2% to 8,726 units (SEC Form 4)
- Chief Leadership & HR Officer Clifford Katherine Lee was granted 128 units of Class A ordinary shares, increasing direct ownership by 2% to 6,659 units (SEC Form 4)
- Chief Strategy & Services Ofcr Sharma Manish was granted 135 units of Class A ordinary shares, increasing direct ownership by 2% to 5,680 units (SEC Form 4)
Latest AHG
- SEC Form 6-K filed by Akso Health Group
- AHG Announces Initiation of World-Class, Proprietary Brain-Computer Interface R&D Program - Targeting the Next Frontier of Human Neurotechnology
- SEC Form 3 filed by new insider Xie Zhongliang
- SEC Form 3 filed by new insider Xu Jianqiang
- SEC Form 3 filed by new insider Liu Wenjuan
- SEC Form 6-K filed by Akso Health Group
- SEC Form 3 filed by Akso Health Group
- SEC Form 3 filed by Akso Health Group
- SEC Form 3 filed by Akso Health Group
- SEC Form 6-K filed by Akso Health Group